University of Iowa Hospitals and Clinics, Iowa City, IA.
National Heart, Lung and Blood Institute, Bethesda, MD.
Curr Probl Cardiol. 2021 Mar;46(3):100599. doi: 10.1016/j.cpcardiol.2020.100599. Epub 2020 May 18.
Cardiovascular disease (CVD), especially ischemic heart disease and stroke, is the major cause of death worldwide, accounting for more than one-third of all deaths annually. Hypertension is the most prevalent and modifiable risk factor of CVD-related deaths. The same is true for obesity, which is currently being recognized as a major global epidemic. The prevalence of obesity in the United States has increased dramatically, from 13.4% in 1960 to 36.5% in 2014, with as much as 70.7% of the American adult population being overweight or obese (CDC). Epidemiological studies have shown that obesity predisposes to hypertension and CVD - with the relationship between markers of obesity and blood pressure being almost linear across different populations. In this review, we discuss systemic and pulmonary hypertension in the context of obesity.
心血管疾病(CVD),尤其是缺血性心脏病和中风,是全球主要的死亡原因,每年占所有死亡人数的三分之一以上。高血压是与 CVD 相关死亡的最普遍和可改变的危险因素。肥胖也是如此,目前肥胖被认为是一个主要的全球流行疾病。美国的肥胖患病率急剧上升,从 1960 年的 13.4%上升到 2014 年的 36.5%,多达 70.7%的美国成年人口超重或肥胖(CDC)。流行病学研究表明,肥胖易患高血压和 CVD,肥胖标志物与血压之间的关系在不同人群中几乎呈线性关系。在这篇综述中,我们讨论了肥胖背景下的系统性和肺动脉高压。